Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,438 signal articles · 135 in last 24h · 154,019 total before filter · latest 55m ago
135last 24h
869last 7d
144● bullish (7d)
99● bearish (7d)
214publishers
AllMacro207Earnings105M&A125Regulatory22Product21Analyst16
✕ clear all filtersticker: PMsentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Philip Morris CEO Is 'Optimistic' About Zyn Potential
Bloomberg14d agoneutralVIDEO
Philip Morris CEO Is 'Optimistic' About Zyn Potential

Jacek Olczak discusses Zyn's strong demand and asking whether those issues have now been resolved. The conversation also focused on Philip Morris International's year-end market share target for Zyn and whether offering larger cans with 15 to 20 pouches could boost revenue as well as margins. He speaks with Romaine Bostick on "The Close."

AIR Global Reports 1H Revenue & Gross Profit Growth, Maintains 2026 Guidance
Exec Edge35d agoneutral
AIR Global Reports 1H Revenue & Gross Profit Growth, Maintains 2026 Guidance

By Karen Roman AIR Global PLC (Nasdaq: AIIR) said first half revenue increased 3.7% to $206.9 million due to flavored shisha molasses revenue growth of 3.4% to $204.7 million, while gross profit rose 2.4% to $116.8 million. Adjusted EBITDA was $71.7 million, flat year-over-year, related to lower shipment volumes partially offset by U.S. tariff refunds. […] The post AIR Global Reports 1H Revenue & Gross Profit Growth, Maintains 2026 Guidance appeared first on ExecEdge.

Philip Morris International Q2 Earnings Call Highlights
MarketBeat64d agoneutral
Philip Morris International Q2 Earnings Call Highlights

Philip Morris International (NYSE:PM) reported what management described as a “very strong” second quarter, with growth led by its international smoke-free products business and a better-than-expected performance in combustibles. Emmanuel Babeau, the company’s group chief financial officer, said Ph

How To Earn $500 A Month From Philip Morris Stock Ahead Of Q2 Earnings
Benzinga64d agoneutral
How To Earn $500 A Month From Philip Morris Stock Ahead Of Q2 Earnings

Philip Morris International Inc‘s (NYSE:PM) investors may be eyeing potential gains from the tobacco company’s dividends ahead of its second-quarter earnings report on Wednesday, July 22. Analysts expect quarterly earnings of $2.05 per share, up from $1.91 per share in...

Tobacco Stocks Are Coming in From the Cold
The Wall Street Journal77d agoneutral
Tobacco Stocks Are Coming in From the Cold

The taboo against owning cigarette stocks hasn’t gone away, but new gray areas are emerging. Investors who bought BAT shares two years ago have roughly doubled their money, a better run than the Magnificent Seven. All tobacco stocks have done well over the period, including Marlboro’s U.S. maker, Altria Group which is up more than 50%.

What A $300,000 Portfolio Can Realistically Pay You Each Month
24/7 Wall St.78d agoneutral
What A $300,000 Portfolio Can Realistically Pay You Each Month

Three hundred thousand dollars sits in an awkward zone for income investors. It is too large to ignore and too small to coast on. With the 10-year Treasury recently around 4.4% and the federal funds target range at 3.50% to 3.75%, the question is how to make this account pay without taking more risk than ... What A $300,000 Portfolio Can Realistically Pay You Each Month

Zyn Can Be Marketed as Safe Alternative to Cigarettes, FDA Says
The Wall Street Journal86d agoneutral
Zyn Can Be Marketed as Safe Alternative to Cigarettes, FDA Says

U.S. officials are allowing Zyn to market itself as being less harmful than traditional cigarettes, making the product the first nicotine pouch on the market to be granted such a distinction. The Food and Drug Administration announced that 20 different Zyn nicotine pouches—including flavors ranging from cool mint to cinnamon—can carry language stating that using the pouches instead of smoking cigarettes puts users at a lower risk of mouth cancer, stroke, heart disease, lung cancer, emphysema and chronic bronchitis. Zyn nicotine pouches, a product of Swedish Match USA, which is owned by Philip Morris International are the most popular in the U.S. They were granted permission to stay on the market in early 2025, the first pouch to receive the authorization.